Trial intelligence / Profile preview

Vitrase for PVD in NPDR

NCT00198471Phase 2Completed

Sponsor
Bausch + Lomb
Start
Jul 2005
Primary completion
Nov 2006
Modality
Therapeutic Enzymes
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of hyaluronidase (ovine) in diabetic retinopathy (DR), sponsored by Bausch + Lomb. Primary endpoint: Vitreous detachment at Day 28. Started Jul 2005; status: completed.

02

Drugs

hyaluronidase (ovine)
03

Conditions

diabetic retinopathy (DR)

Beyond the preview

Go deeper on NCT00198471.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00198471.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call